1-11 of 11
Wenming Chen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from Lummicar-1: A Phase 1 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Chinese Subjects with Relapsed and/or Refractory Multiple Myeloma

Free
Wenming Chen, MD PhD, Chengcheng Fu, MD PhD, Zhen Cai, MD PhD, Zonghai Li, MD PhD, Huijuan Wang, MD PhD, Lingzhi Yan, MD PhD, Yin Wu, MD PhD, Xiaolan Shi, MD PhD, Wen Gao, MD, Shuang Yan, MD, Wei Wang, MDPhD, Xiaoyan Han, MD PhD, Gaofeng Zheng, MD PhD, Yanling Wen, MD, Jun Xiao, MD, Huamao Wang, PhD, Hong Ma, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49–50.
https://doi.org/10.1182/blood-2020-140727
Published: 2020
Journal Articles

T(4; 14) Is Not a Poor Prognostic Factor for Newly Diagnosed Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation in New Drug Era

Free
Chuanying Geng, MD, Guangzhong Yang, Wen Gao, MD, Huijuan Wang, Yanchen Li, Yin WU, Huixing Zhou, MD, Zhiyao Zhang, MD, Yuan Jian, Wenming Chen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30.
https://doi.org/10.1182/blood-2020-140268
Published: 2020
Journal Articles

Aberrant Expression of Mir-20a in Serum Exosomes of Multiple Myeloma Lead Abnormal Expression of HIF-1 Signaling Pathway Related Proteins

Free
Zhiyao Zhang, MD, Huixing Zhou, MD, Chuanying Geng, MD, Wen Gao, MD, Wenming Chen, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43.
https://doi.org/10.1182/blood-2020-141182
Published: 2020
Journal Articles

Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study

Free
Shaji K. Kumar, MD, Jin Lu, MDProf, Yang Terry Liu, PhD, Max Bittrich, MD, Juan Du, MD, Hartmut Goldschmidt, MD, Charalampia Kyriakou, MD PhD, Donna E Reece, MD, Kihyun Kim, MD PhD, Maria-Victoria Mateos, Veronica Gonzalez De La Calle, MD PhD, Wenming Chen, MD, Heinz Ludwig, MD, Giampaolo Merlini, MD, Silvia Mangiacavalli, Meletios A. Dimopoulos, MD, Eftathios Kastritis, Chang-Ki Min, MD PhD, Graca Esteves, Andrew J. Yee, MD, Noopur S. Raje, MD, Emily Rosta, Anja Haltner, Chris Cameron, Brian G.M. Durie, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3066.
https://doi.org/10.1182/blood-2019-126867
Published: 2019
Journal Articles

IgD Myeloma: Clinical Features and Outcome from a Multicenter Retrospective Study in Chinese and Korean of 308 Patients from Asian Myeloma Network (AMN) Project

Free
Juan Du, PhD MD, Weijun Fu, MD, Jae Hoon Lee, MD PhD, Chunyang Zhang, MD, Kihyun Kim, MD, Ai Jun Liu, MD, Jin Lu, Cheolwon Suh, MD PhD, Min Kyoung Kim, MD PhD, Wenming Chen, MD, Jin Liu, Hua Jiang, MD, Jian Hou, PhD MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5409.
https://doi.org/10.1182/blood.V130.Suppl_1.5409.5409
Published: 2017
Journal Articles

Which Should be Pursued, Cumulative Dose or Dose Intensity: A Real-World Effectiveness Analysis of Bortezomib-Based First Line Treatment for Untreated Multiple Myeloma Patients

Free
Shenmiao Yang, MD, Aijun Liu, MD, Yuping Zhong, MD, Xiaojun Huang, MDPhD, Wenming Chen, MD, Jin Lu
Journal: Blood
Blood (2015) 126 (23): 4247.
https://doi.org/10.1182/blood.V126.23.4247.4247
Published: 2015
Journal Articles

Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma

Free
Wenming Chen, MD, Peng Wei, PhD, Shifang Yang, PhD, Xiangjun Zheng, Lugui Qiu, MD, Jian Hou, MD PhD, Xuejun Zhang, MD, Zhao Wang, Xiaoyan Ke, MD PhD, Ling Pan, MDPhD, Hongyan Pang, PhD
Journal: Blood
Blood (2014) 124 (21): 3478.
https://doi.org/10.1182/blood.V124.21.3478.3478
Published: 2014
Journal Articles

Clinical Profile of Multiple Myeloma in Asia - an Asian Myeloma Network (AMN) Study

Free
Jae Hoon Lee, Kihyun Kim, MD, Jin Seok Kim, Chang Ki Min, MD, Sung-Soo Yoon, MD, Kazuyuki Shimizu, MD, Takaaki Chou, MD, Hiroshi Kosugi, MD, Kenshi Suzuki, MD, PhD, Hiroyuki Hata, MD, PhD, Wenming Chen, MD, Jian Hou, MD, PhD, Jin Lu, MD, Shang-Yi Huang, MD, PhD, Wee-Joo Chng, MD, Daryl Tan, MD, Gerrard Teoh, MD, James Chor Sang Chim, MD, Noppadol Siritanaratkul, MD, Weerasak Nawarawong, MD, Brian GM Durie, MD
Journal: Blood
Blood (2012) 120 (21): 5035.
https://doi.org/10.1182/blood.V120.21.5035.5035
Published: 2012
Journal Articles

Recombinant Circularly Permuted TRAIL (CPT) for the Treatment of Relapsed or Refractory Multiple Myeloma: An Open-Label, Multicenter Phase II Clinical Trial

Free
Wenming Chen, MD, Lugui Qiu, MD, Jian Hou, MD, PhD, Yaozhong Zhao, Ling Pan, Shifang Yang, PhD, Yun Leng, Hao Xi, Xuejun Zhang, Junsheng Cui, Na Wei
Journal: Blood
Blood (2012) 120 (21): 78.
https://doi.org/10.1182/blood.V120.21.78.78
Published: 2012
Journal Articles

Phase Ib Study of Recombinant Circularly Permuted TRAIL (CPT) in Relapsed or Refractory multiple Myeloma Patients

Free
Wenming Chen, MD, Lugui Qiu, MD, Jian Hou, MD, PhD, Xuejun Zhang, Xiaoyan Ke, MD, PhD, Zhao Wang, MD, PhD, Fang Zhou, Shifang Yang, PhD, Yaozhong Zhao, Yun Leng, Hao Xi, Fuxu Wang, Bing Zhu
Journal: Blood
Blood (2012) 120 (21): 1857.
https://doi.org/10.1182/blood.V120.21.1857.1857
Published: 2012
Journal Articles

Circularly Permuted TRAIL (CPT) combined with Thalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma: An Open-Label, Multicenter Phase II Clinical Trial.

Free
Wenming Chen, MD, Jian Hou, MD, PhD, Yaozhong Zhao, Lugui Qiu, MD, Xiaoyan Ke, MD, PhD, Zhao Wang, MD, PhD, Yun Leng, Hongmei Jing, Hao Xi, Xiangjun Zheng, Fuxu Wang, Bing Zhu, Shifang Yang, PhD
Journal: Blood
Blood (2012) 120 (21): 2958.
https://doi.org/10.1182/blood.V120.21.2958.2958
Published: 2012